Clinical Research Directory
Browse clinical research sites, groups, and studies.
Stem Cell Therapy for Limbal Stem Cell Deficiency
Sponsor: University of California, Los Angeles
Summary
This phase I study will collect preliminary information on the activity and safety of cLSC. We will investigate the ability to manufacture and transplant cLSC onto the cornea successfully at the time of surgery (feasibility), and have cLSC begin to populate the ocular surface (efficacy) without serious adverse events (safety).
Official title: Safety and Feasibility of Cultivated Autologous Limbal Stem Cells (cLSC) for Limbal Stem Cell Deficiency
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2020-09-30
Completion Date
2027-04-30
Last Updated
2026-02-10
Healthy Volunteers
No
Conditions
Interventions
cLSC
Transplantation of cLSC
Scleral contact lens (SCL)
Scleral contact lens device (SCL) will be used to stabilize and improve ocular surface.
Locations (1)
University of California
Los Angeles, California, United States